SRX Global Inc. (SRXH)
NYSEAMERICAN: SRXH · Real-Time Price · USD
1.680
-0.030 (-1.75%)
At close: Aug 31, 2026, 4:00 PM EDT
1.670
-0.010 (-0.60%)
After-hours: Aug 31, 2026, 8:00 PM EDT
SRX Global Revenue
SRX Global had revenue of $3.39M in the quarter ending June 30, 2026, with 26.90% growth. This brings the company's revenue in the last twelve months to $13.50M, up 405.01% year-over-year. In the fiscal year ending September 30, 2025, SRX Global had annual revenue of $6.53M.
Revenue (ttm)
$13.50M
Revenue Growth
+405.01%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
7
Market Cap
32.79M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 6.53M | - | - |
| Sep 30, 2024 | - | - | - |
| Dec 31, 2023 | 38.59M | -16.07M | -29.40% |
| Dec 31, 2022 | 54.66M | 8.65M | 18.81% |
| Dec 31, 2021 | 46.01M | 3.42M | 8.02% |
| Dec 31, 2020 | 42.59M | 27.01M | 173.42% |
| Dec 31, 2019 | 15.58M | 792.00K | 5.36% |
| Dec 31, 2018 | 14.79M | - | - |
| Aug 31, 2018 | - | - | - |
| Dec 31, 2017 | 0 | - | - |
| Aug 31, 2017 | - | - | - |
| Aug 31, 2016 | 43.00 | - | - |
| Aug 31, 2015 | - | - | - |
| Aug 31, 2014 | - | - | - |
| Aug 31, 2013 | - | - | - |
| Aug 31, 2012 | - | - | - |
| Aug 31, 2011 | - | - | - |
| Aug 31, 2010 | - | - | - |
| Aug 31, 2009 | - | - | - |
| Aug 31, 2008 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| The Hain Celestial Group | 1.45B |
| Bridgford Foods | 228.22M |
| LifeVantage | 182.59M |
| Coffee Holding Co. | 99.35M |
| Laird Superfood | 81.48M |
| DDC Enterprise | 39.18M |
| BioHarvest Sciences | 35.48M |
| Borealis Foods | 30.60M |
SRXH News
- 16 hours ago - SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers - GlobeNewsWire
- 18 days ago - SRX Global Inc. Announces Fiscal Third Quarter 2026 Financial Results - GlobeNewsWire
- 25 days ago - SRX Global to Host Fiscal Third Quarter 2026 Conference Call on August 13 at 4:30 p.m. ET - GlobeNewsWire
- 27 days ago - SRX Global acquires stake in Vistagen - TheFly
- 27 days ago - SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN) - GlobeNewsWire
- 4 weeks ago - SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger - GlobeNewsWire
- 4 weeks ago - SRX Global acquires Jersey Mike’s shares in IPO - TheFly
- 4 weeks ago - SRX Global Acquires Shares in Jersey Mike's $1 Billion Initial Public Offering - GlobeNewsWire